Han, R., Yang, H., Lu, L., Lin, L. (2025). Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Scientific Reports. https://doi.org/10.1038/s41598-025-11770-9